CYTO Innovation: What We Say and How We Say It Are the Most Powerful Tools We Have
Recorded On: 08/04/2020
- Registration Closed
Andrea Cossarizza, MD, PhD, ISAC Past-President, Full Professor of Pathology and Immunology; Vice President, Faculty of Medicine, University of Modena and Reggio Emilia
Jonni Moore, PhD, ISAC President, Professor of Pathology and Laboratory Medicine; Faculty Director, Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource Laboratory; Executive Director, PathBioresource, Perelman School of Medicine of the University of Pennsylvania
Master of Ceremonies Welcome
Pratip Chattopadhyay, PhD, Associate Professor of Pathology; Director, Precision Immunology Incubator, Isaac and Laura Perlmutter Cancer Center, NYU-Langone Medical Center
Nicole Poulton, PhD, Director, Center for Aquatic Cytometry, Bigelow Laboratory for Ocean Sciences
9:00 - 10:00am
CYTO Innovation Session
The speakers will examine, from two complementary directions, the key success factors and challenges for commercializing and communicating about innovation in life sciences technologies for maximum impact. First geared especially toward technical founders. Second is an appreciation of what you say and how you say it being the most powerful tools you have to convey who you are and what you stand for. The session promises to have wide appeal touching upon critical skills for success. This masterclass breaks new ground for ISAC with an in-depth interactive speaker conversation and Q&A with the audience.
Agenda and Speakers
Elena Holden, MD, President and CEO, Tomocube USA, Inc.
Commercializing and Communicating Innovation
Jenny Rooke, PhD, Founder and Managing Director, Genoa Ventures
Ursula Errington, Founder, Hard Truth Media
Andrea Cossarizza, MD, PhD
Full Professor of Pathology and Immunology; Vice President, Faculty of Medicine at the University of Modena and Reggio Emilia
Andrea Cossarizza is a Full Professor of Pathology and Immunology, Vice President of the Faculty of Medicine at the University of Modena and Reggio Emilia, and current Past President of ISAC. He has been studying the molecular and cellular basis of several diseases that involve the immune system for 35 years. He is currently at the forefront of the fight against COVID-19, and has provided the first contributions regarding the importance of cytometry in understanding the immune response to SARS-CoV-2. As of May 2020, he has published 332 papers on peer reviewed journal, has an H index of 79 and has received over 33,000 citations.
Pratip Chattopadhyay, PhD
Associate Professor of Pathology; Director, Precision Immunology Incubator, Isaac and Laura Perlmutter Cancer Center, NYU-Langone Medical Center
Pratip Chattopadhyay, PhD is an Associate Professor (Pathology) and founding Director of NYU Langone Health’s Precision Immunology Laboratory (PIL). His laboratory performs independent research in tumor immunology and provides cutting-edge immune monitoring services for a wide variety of biomedical disciplines (cancer, infectious disease, rheumatology). We use high parameter cytometry technologies, including 30-parameter flow cytometry and combined protein/mRNA analysis by RNA sequencing (molecular cytometry), to reveal biomarkers that predict patient outcomes, better understand disease pathogenesis, and inform rational design of combination drug therapies.
Nicole Poulton, PhD
Director, Center for Aquatic Cytometry, Bigelow Laboratory for Ocean Sciences
Dr. Nicole Poulton is the Director of the Center for Aquatic Cytometry, and a Research Scientist at Bigelow Laboratory for Ocean Sciences. Nicole’s main research interests focus on phytoplankton and aquatic microbial ecology, including harmful algal blooms and the role of phytoplankton in the global carbon cycle. Her research uses aquatic flow and imaging cytometry, single cell sorting and genomics to examine phytoplankton and bacterioplankton in the oceanic environment. She has over 25 years of flow cytometric experience within the aquatic sciences. Nicole received her PhD in Biological Oceanography from the Massachusetts Institute of Technology and Woods Hole Oceanographic Institution. She joined Bigelow Laboratory as a Research Scientist in 2008 and became the Director of the Center for Aquatic Cytometry in 2014. Nicole is very active in education and outreach and is also an ISAC Shared Resource Laboratory Emerging Leader (2017-2021).
Jonni Moore, PhD
Professor of Pathology and Laboratory Medicine; Faculty Director, Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource Laboratory; Executive Director, PathBioresource, Perelman School of Medicine of the University of Pennsylvania
Jonni Moore, Ph.D. is a Professor of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania, Scientific Director of the Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource, and Emeritus Director, Founder, and currently Senior Advisor of the Clinical Flow Cytometry Laboratory at the Hospital of the University of Pennsylvania. She is currently the President of ISAC. She received her PhD from Thomas Jefferson University in Philadelphia in Microbiology and completed a postdoc with Peter Nowell, MD at the University of Pennsylvania.
Elena Holden, MD (Moderator)
President and CEO, Tomocube USA, Inc.
Dr. Holden’s area of expertise and interests are in advancing the commercialization of breakthrough developments in cancer cell biology, personalized biomarkers of disease progression and therapy together with the implementation of imaging cytometry systems for cell-based analyses. During her career she led multi-functional teams as Chief Strategic Marketing at Thorlabs, President and CEO of Compucyte Corporation, and Business Development Manager/Regional Director at Chiron Diagnostics. Today Elena leads development and commercialization of IDV products as President and CEO, Tomocube USA, Inc. and Chief Strategy Officer, TomoCube, South Korea. She is also an Associate Editor of the Cytometry Part A, the official journal of ISAC and a committee member of the SPIE/ Photonics West Quantitative Phase Imaging.
Jenny Rooke, PhD
Founder and Managing Director, Genoa Ventures
For over a decade, Genoa Ventures’ founder and managing director Dr. Jenny Rooke has been deploying capital at the frontiers of life sciences innovation, with a penchant for technology-fueled solutions and category-defying opportunities. Jenny got her start in venture at Fidelity Biosciences, a Cambridge-based healthcare VC, during their Fund I formation. Jenny then brought her unique toolkit of genetics domain expertise, strategic business acumen, and venture investing to the Gates Foundation, where she deployed and managed over $250M in funding in genetic engineering, diagnostics, and synthetic biology. She also played a key role in establishing the foundation’s investing function. In 2014, Dr. Rooke began independently investing under the brand 5 Prime Ventures, financing her investments using what has become the largest life sciences syndicate on AngelList, and one of the highest-performing AngelList syndicates of any sector. Jenny founded Genoa Ventures in 2018, building on the 5 Prime Ventures track record, in order to scale a proven, differentiated investing strategy, to ensure continued access to the very best deals, and to maximize portfolio returns
Founder, Hard Truth Media
Ursula Errington is a former news correspondent and business news presenter for Sky News in the UK. During a broadcast career of more than a decade, she also worked for BBC regional news as a news anchor and Monocle 24 Radio as a breakfast presenter on the station’s flagship current affairs program. During her career as a journalist, Ursula worked on a huge variety of stories across domestic, foreign, political and business news, bringing her incisive style of interviewing to millions of viewers and listeners. She has interviewed two UK Prime Ministers and three Chancellors of the Exchequer, household name CEOs and countless academics, analysts, experts and members of the public with a story to tell. Today, Ursula runs Hard Truth Media Ltd and is a Special Communications Advisor to VIPs and C-Suite executives. She travels the world preparing them to deliver speeches, participate in panel discussions and conduct media interviews. Ursula is passionate about helping clients develop clear, authentic, audience-centric messages they can deliver with ease, because they truly believe in them.
CMLE Credit: 1.0